ES2042818T3 - Agente terapeutico para la trombocitopenia. - Google Patents

Agente terapeutico para la trombocitopenia.

Info

Publication number
ES2042818T3
ES2042818T3 ES89102324T ES89102324T ES2042818T3 ES 2042818 T3 ES2042818 T3 ES 2042818T3 ES 89102324 T ES89102324 T ES 89102324T ES 89102324 T ES89102324 T ES 89102324T ES 2042818 T3 ES2042818 T3 ES 2042818T3
Authority
ES
Spain
Prior art keywords
thrombocitopenia
therapeutic agent
monocytemaciophagus
hematopeyetic
colonies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89102324T
Other languages
English (en)
Inventor
Fumimaro Takaku
Kazuo Motoyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GREEN CROSS CORP
Morinaga Milk Industry Co Ltd
Mitsubishi Tanabe Pharma Corp
Original Assignee
GREEN CROSS CORP
Green Cross Corp Japan
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GREEN CROSS CORP, Green Cross Corp Japan, Morinaga Milk Industry Co Ltd filed Critical GREEN CROSS CORP
Application granted granted Critical
Publication of ES2042818T3 publication Critical patent/ES2042818T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN AGENTE TERAPEUTICO PARA LA TROMBOCITOPENIA DEBIDA A ENFERMEDADES HEMATOPEYETICAS ORIGINADAS POR VARIAS CAUSAS COMPRENDE COMO INGREDIENTE ACTIVO UN FACTOR ESTIMULANTE DE COLONIAS DE MONOCITEMACIOFAGOS ESPECIFICOS HUMANOS. SE ADMINISTRA PARA EL TRATAMIENTPO Y/O PREVENCION DE CADA TROMBOCITOPENIA.
ES89102324T 1988-02-10 1989-02-10 Agente terapeutico para la trombocitopenia. Expired - Lifetime ES2042818T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63029819A JPH0611705B2 (ja) 1988-02-10 1988-02-10 血小板減少症治療剤

Publications (1)

Publication Number Publication Date
ES2042818T3 true ES2042818T3 (es) 1993-12-16

Family

ID=12286632

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89102324T Expired - Lifetime ES2042818T3 (es) 1988-02-10 1989-02-10 Agente terapeutico para la trombocitopenia.

Country Status (7)

Country Link
US (1) US5114710A (es)
EP (1) EP0328132B1 (es)
JP (1) JPH0611705B2 (es)
KR (1) KR970009890B1 (es)
CA (1) CA1332149C (es)
DE (1) DE68907933T2 (es)
ES (1) ES2042818T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888495A (en) * 1988-05-23 1999-03-30 Genetics Institute, Inc. Method of producing storage stable M-CSF lyophilizates
JPH07103041B2 (ja) * 1989-04-04 1995-11-08 森永乳業株式会社 悪性腫瘍治療補助剤
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US7294331B2 (en) * 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
US7150992B1 (en) 1995-10-04 2006-12-19 Innunex Corporation Methods of preparing dendritic cells with flt3-ligand and antigen
US7361330B2 (en) * 1995-10-04 2008-04-22 Immunex Corporation Methods of using flt3-ligand in the treatment of fibrosarcoma
US20020034517A1 (en) * 1995-10-04 2002-03-21 Kenneth Brasel Dendritic cell stimulatory factor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
US4230697A (en) * 1978-07-03 1980-10-28 Morinaga Milk Industry Co. Ltd. Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same
WO1986004587A1 (en) * 1985-02-05 1986-08-14 Cetus Corporation Purification of native colony stimulating factor-1
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
EP0276551B1 (en) * 1986-12-07 1992-03-18 Morinaga Milk Industry Co., Ltd. Colony-stimulating factor and method for preparation thereof

Also Published As

Publication number Publication date
JPH0611705B2 (ja) 1994-02-16
DE68907933D1 (en) 1993-09-09
JPH01207244A (ja) 1989-08-21
EP0328132B1 (en) 1993-08-04
DE68907933T2 (de) 1993-12-16
KR890012664A (ko) 1989-09-18
EP0328132A2 (en) 1989-08-16
US5114710A (en) 1992-05-19
EP0328132A3 (en) 1990-04-18
CA1332149C (en) 1994-09-27
KR970009890B1 (ko) 1997-06-19

Similar Documents

Publication Publication Date Title
ES2055911T3 (es) Compuesto farmaceutico adelgazante.
ATE410506T1 (de) Behandlung der pompeschen krankheit
ES2188652T3 (es) Sistema de direccionado de farmacos, metodos de fabricacion y uso del mismo.
NO20034684L (no) Mikroprojeksjonsanordning med belegg inneholdende et fordelaktig middel
ATE51342T1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
ES2052733T3 (es) Dispositivo electroterapeutico de baja frecuencia.
JPS57212114A (en) Capsule containing allergen activator and preparation therefor
ES2191329T3 (es) Utilizacion de xantofilos en medicamentos para la mejora de la duracion de la funcion muscular o el tratamiento de trastornos o enfermedades musculares.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
NZ517038A (en) Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction
DE60003837D1 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
ES2106319T3 (es) Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
ES2138602T3 (es) Agente terapeutico para la amenaza de aborto.
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
AR003979A1 (es) Administracion transdermica de vorozol.
ES8304058A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10,14-hexadecapentaenoico.
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
FR2632525B1 (fr) Application therapeutique de la myeloperoxydase humaine
ES2192810T3 (es) Empleo de monoxidina como medicamento de actividad estimulante de la termogenesis.
FR2437832A1 (fr) Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
Roy Laser biostimulation: Will it be proven effective?.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 328132

Country of ref document: ES